Hans-Christian Pommergaard
Overview
Explore the profile of Hans-Christian Pommergaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
1159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahmad Al-Saffar H, Schultz N, Larsen P, Fallentin E, Willemoe G, Renteria Ramirez D, et al.
Scand J Gastroenterol
. 2024 Dec;
:1-8.
PMID: 39692292
Background: Perihilar cholangiocarcinoma (pCCA) has a 5-year overall survival (OS) ranging from 10-40%, following resection. However, prognostic models for postoperative outcomes are limited by long study timespan and variations in...
2.
Klubien J, Knofler L, Larsen P, Nielsen S, Fukumori D, Hillingso J, et al.
Surg Endosc
. 2024 Aug;
38(10):5785-5792.
PMID: 39145873
Background: Ablation is an effective, parenchymal-sparing treatment for primary liver cancer and liver metastases. The purpose of this study was to report our initial experience with laparoscopic microwave ablation regarding...
3.
Mortensen L, Andresen K, Thygesen L, Pommergaard H, Rosenberg J
J Clin Med
. 2024 May;
13(9).
PMID: 38731032
An association between diverticulitis and colon cancer has been proposed. The evidence is conflicting, and the guidelines differ regarding recommended follow-up with colonoscopy after an episode of diverticulitis. To guide...
4.
Klubien J, Knofler L, Poulsen A, Larsen P, Pless T, Knudsen A, et al.
Eur J Surg Oncol
. 2024 May;
50(7):108366.
PMID: 38692100
Introduction: Despite limited evidence, technique efficacy and complications may be important short-term outcomes after ablation for hepatocellular carcinoma (HCC). We aimed to report these outcomes after ablation as the first...
5.
Akdag D, Rasmussen A, Nielsen S, Moller D, Togsverd-Bo K, Wenande E, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539557
(1) Background: Skin cancer is the most common cancer in transplant recipients. Timely and regular screening may reduce advanced disease. The study aimed to determine referral rates to screening, the...
6.
Nordkild S, Ahlborn L, Yde C, Kugler J, Klubien J, Akdag D, et al.
Mol Biol Rep
. 2024 Mar;
51(1):450.
PMID: 38536546
Introduction: Genetic mutations and amplifications found in hepatocellular carcinoma (HCC) have a potentially prognostic impact. The aim of this study was to investigate the prognostic value of mutations and amplifications...
7.
Arentoft N, Fialla A, Krohn P, Patursson M, Thudium R, Suarez-Zdunek M, et al.
Front Immunol
. 2024 Feb;
15:1330923.
PMID: 38361926
Background: Fraction of exhaled nitric oxide with an expiratory flow of 50 mL/s (FNO) is a biomarker of eosinophilic airway inflammation. Liver transplant recipients have an increased risk of pulmonary...
8.
9.
Riis T, Moller D, Hogh J, Knudsen A, Rostved A, Akdag D, et al.
APMIS
. 2023 Jan;
131(4):135-141.
PMID: 36680559
Liver transplant recipients receive immunosuppressive treatment to avoid organ rejection, increasing the risk of developing de novo cancer after transplantation. We investigated the cumulative incidence of de novo cancer in...
10.
Holmager P, Langer S, Kjaer A, Ringholm L, Garbyal R, Pommergaard H, et al.
Curr Treat Options Oncol
. 2022 Apr;
23(6):806-817.
PMID: 35362798
In the 2019 WHO guidelines, the classification of gastro-entero-pancreatic neuroendocrine neoplasms (GEP NEN) has changed from one being based on Ki-67 proliferation index alone to one that also includes tumor...